alexa Bone-marrow stem cells as a source for cell therapy.


Cardiovascular Therapy: Open Access

Author(s): Chiu RC, Chiu RC

Abstract Share this page

Abstract Bone marrow stroma contains a subgroup of cells which can be guided in vitro to differentiate, and express cardiomyocyte phenotype. In vivo, these cells can become cardiomyocytes when implanted into the myocardium, in response to signals from the microenvironment. They appear to participate in the physiologic healing process of tissue injury, such as myocardial infarction, by being recruited from the bone marrow, traffic via the circulation and home in to the injured site. Thus such cells may be employed to therapeutically augment the myocardial repair for patients who suffer cardiac damages, which may lead to heart failure. Optimization of the cell implant strategy, and further exploration of the preliminary findings that such adult stem cells may be uniquely immuno-tolerant and thus may be used as "universal donors", will further enhance the clinical significance of adult stem cell-based regenerative therapy for heart failure.
This article was published in Heart Fail Rev and referenced in Cardiovascular Therapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version